Skip to main content

Search

Clear
Filter by Type
Filter by Topics
Filter by Symptoms & Conditions
Filter by Year
CMS Proposes New Model That Could Highlight PTs’ Impact in Joint Replacement

May 22, 2026/Statement

In the model, physical therapists would serve as a critical component of some of Medicare’s most common surgical interventions.

Applying the Code of Ethics: Real-World Scenarios

Feb 1, 2026/Article

Practical examples of how the Code of Ethics for the Physical Therapy Profession offers clear guidance for PTs and PTAs.

Benign Paroxysmal Positional Vertigo (BPPV)

Oct 24, 2011/Clinical Summary

PTs confirm a diagnosis of BPPV by observation of nystagmus (involuntary eye movement) when the patient is placed in a position that provokes symptoms.

Forefoot Alignment Measurement

Jan 10, 2013/Test & Measure

For patients with foot and ankle disorders

The Good Stuff: Members and the Profession in the Media, June 2021

Jun 16, 2021/Roundup

Our monthly roundup of local and national reporting featuring members on a range of topics.

Viewpoints

Sep 1, 2017/Magazine

- Keeping Pain Out of the Red Zone\r\n - First Choice for a Second Career\r\n - Defining Moment: Amputation and Ambulation

Takeaways From the Proposed 2023 Medicare Physician Fee Schedule, Part 2

Jul 12, 2022/News

MIPS reporting, value pathways, virtual supervision, and more.

Viewpoints

Oct 1, 2017/Magazine

A friend of mine, knowing I enjoy reading about World War II history, recommended that I read author Daniel James Brown's The Boys in the Boat.1 Assuming that "boat" meant submarine or destroyer, I eagerly downloaded this book onto my e-reader … and discovered the world of crew-a rowing sport about which

You Can't Be in Two Places at Once

Nov 1, 2021/Column

We all try to balance our work and personal lives, but some situations can create ethical risk factors that might result in poor decisions.

Coronavirus Update: December 7

Dec 7, 2022/Roundup

APTA's message on long COVID, physical activity and vaccination effectiveness, long COVID costs, and more.